Shionogi & Co., Ltd

(PINK:SGIOF)

Latest On Shionogi & Co., Ltd (SGIOF):

Date/Time Type Description Signal Details
2023-05-11 13:27 ESTNewsShionogi & Co. GAAP EPS of ¥621.31, revenue of ¥426.7BN/A
2023-02-06 11:56 ESTNewsShionogi & Co. reports Q3 resultsN/A
2022-08-01 19:05 ESTNewsShionogi & Co. GAAP EPS of ¥115.13, revenue of ¥71.84BN/A
2022-07-20 15:36 ESTNewsShionogi faces setback for COVID pill as Japan delays authorization againN/A
2022-02-01 19:28 ESTNewsGilead settles patent dispute with ViiV Healthcare over HIV drugN/A
2022-01-31 10:27 ESTNewsShionogi & Co. GAAP EPS of ¥235.43, revenue of ¥219.63BN/A
2021-12-20 18:36 ESTNewsGSK/Pfizer's Apretude approved as long-acting, injectable HIV PrEP treatmentN/A
2021-10-21 21:36 ESTNewsShionogi begins phase 2/3 trial of potential COVID-19 vaccine in JapanN/A
2021-10-21 21:36 ESTNewsShionogi's oral drug for COVID-19 seen to be safe in phase 1 trialN/A
2021-03-30 06:04 ESTDividendA dividend of $53 has been announced on May 11, 2020. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 30, 2021.Neutral
2021-02-04 09:16 ESTFinancialsCompany financials have been released.Neutral
2021-02-02 13:34 ESTEarnings EstimateAn EPS average of $0.60 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-02 00:18 ESTNewsShionogi & Co. reports 9M resultsN/A
2020-11-26 22:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:09 ESTFinancialsCompany financials have been released.Neutral
2020-10-17 10:17 ESTNewsEuropean advisory group backs ViiV's cabotegravir and rilpivirine regimen in HIVN/A
2020-10-13 14:40 ESTEarnings EstimateAn EPS average of $0.69 is estimated for the quarter ending on December 31, 2020.Sell
2020-09-26 15:02 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:08 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:03 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 14:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-02 06:09 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:19 ESTNewsShionogi & Co. reports Q1 resultsN/A
2020-07-30 18:47 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:58 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:52 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:22 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:29 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:35 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:11 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 10:14 ESTEarnings EstimateAn EPS average of $3.71 is estimated for the 2022 year.Buy
2020-05-27 07:12 ESTFinancialsCompany financials have been released.Neutral
2020-05-23 22:09 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:46 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 07:26 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:23 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:12 ESTFinancialsCompany financials have been released.Neutral
2020-04-08 18:18 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 22:46 ESTFinancialsCompany financials have been released.Neutral
2020-03-30 06:06 ESTDividendA dividend of $50 has been announced on May 9, 2019. It will be paid Jan 1, 1970 with an ex-dividend date of Mar 30, 2020.Neutral
2020-03-25 22:18 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:51 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 23:55 ESTFinancialsCompany financials have been released.Neutral
2020-02-23 00:48 ESTEarningsEarnings have been released on December 31, 2019, with $127.00 earnings per share.Buy

About Shionogi & Co., Ltd (SGIOF):

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

See Advanced Chart

General

  • Name Shionogi & Co., Ltd
  • Symbol SGIOF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 5,222
  • Fiscal Year EndMarch
  • Web URLhttp://www.shionogi.com
View More

Valuation

  • Trailing PE 16.64
  • Forward PE 17.15
  • Price/Sales (Trailing 12 Mt.) 6.12
  • Price/Book (Most Recent Quarter) 2.18
  • Enterprise Value Revenue 0.04
  • Enterprise Value EBITDA 0.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $3.38
  • Next Year EPS Estimate $3.00
  • Profit Margin 39%
  • Return on Assets 10%
  • Return on Equity 15%
  • Earnings Per Share $3.30
  • Revenue Per Share $0
  • Gross Profit 276.59 billion
  • Quarterly Earnings Growth -18%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 35.8
  • Environment Score 3.45
  • Social Score 18.47
  • Governance Score 15.38
  • Controversy Level 1
View More

Highlights

  • Market Capitalization 16.87 billion
  • PEG Ratio 14289.2
  • Book Value Per Share $18.64
View More

Share Statistics

  • Shares Outstanding 303.26 million
  • Shares Float 305.51 million
  • % Held by Insiders 889%
  • % Held by Institutions 53.81%
View More

Technicals

  • Beta 0.9
  • 52 Week High $67.52
  • 52 Week Low $39.08
  • 50 Day Moving Average 55.1
  • 200 Day Moving Average 53.94
View More

Dividends

  • Forward Annual Dividend Rate $1.02
  • Forward Annual Dividend Yield 1.91%
  • Payout Ratio 39%
  • Dividend Date 2018-06-21
  • ExDividend Date 2020-09-29
  • Dividend Per Share $0.8
  • Dividend Yield 0%
View More

Shionogi & Co., Ltd (SGIOF) Dividend Calendar:

SGIOF's last dividend payment was made to shareholders on June 21, 2018.
Shionogi & Co., Ltd pays out 39% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Shionogi & Co., Ltd (SGIOF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A$1.09$0.6762.69%
2020-09-302020-12-31$N/A$1.15
2020-06-302020-09-30$N/A$0.85$77.20-98.9%
2020-03-312020-06-30$N/A$0.66$112.46-99.42%
2019-12-312020-03-31$852.81 million$0.96$105.90-99.1%
2019-09-302019-12-31$755.48 million$1.17$76.39-98.47%
2019-06-302019-09-30$730.55 million$0.81$101.45-99.2%
2019-03-312019-06-30$884.37 million$0.73$93.00-99.22%
2018-12-312019-03-31$885.59 million$1.11
2018-09-302018-12-31$699.4 million$1.06$107.69-99.01%
2018-06-302018-09-30$798.27 million$0.72$52.16-98.62%
2018-03-312018-06-30$767.79 million$0.90$55.80-98.38%
2017-12-312018-03-31$809.46 million$0.86$72.70-98.82%
2017-09-302017-12-31$861.52 million$0.81$50.30-98.4%
2017-06-302017-09-30$667.58 million$0.94$45.90-97.95%
2017-03-312017-06-30$82.36 billion$0.44$65.30-99.33%
2016-12-312017-03-31$101.43 billion$0.45$76.00-99.4%
2016-09-302016-12-31$0.95$39.90-97.61%
2016-06-302016-09-30$0.56$29.90-98.14%
2016-03-312016-06-30$0.37$64.30-99.43%
2015-12-312016-03-31$0.67
2015-09-302015-12-31$0.51
2015-06-302015-09-30$0.30$16.20-98.17%
2015-03-312015-06-30$0.24
2014-12-312015-03-31$0.45$27.65-98.38%
2014-09-302014-12-31$0.41$23.20-98.22%
2014-06-302014-09-30-$0.03
2014-03-312014-06-30$0.30$22.40-98.68%
2013-12-312014-03-31$0.13$0.42-68.26%
2013-09-302013-12-31$0.45
2013-06-302013-09-30$0.32
2013-03-312013-06-30$0.33
2012-12-312013-03-31$1.22
2012-09-302012-12-31$0.47
2012-06-302012-09-30$0.30
2012-03-312012-06-30$0.26
2011-12-312012-03-31$0.31
2011-09-302011-12-31$0.40
2011-06-302011-09-30$0.17
2011-03-312011-06-30$0.14
2010-12-312011-03-31$0.23
2010-09-302010-12-31$0.25
2010-06-302010-06-30$0.16
2010-03-312010-03-31$0.43
2009-12-312009-12-31$0.46
2009-09-302009-09-30$0.22
2009-06-302009-06-30$0.14

Shionogi & Co., Ltd (SGIOF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Shionogi & Co., Ltd (SGIOF) Chart:

Shionogi & Co., Ltd (SGIOF) News:

Below you will find a list of latest news for Shionogi & Co., Ltd (SGIOF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Shionogi & Co., Ltd (SGIOF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Shionogi & Co., Ltd (SGIOF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2013-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281721/000090866213000137/0000908662-13-000137-index.htm
2013-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281721/000090866213000161/0000908662-13-000161-index.htm
2014-02-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1281721/000095010314001100/0000950103-14-001100-index.htm
2014-07-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1281721/000095010314004866/0000950103-14-004866-index.htm
2015-12-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1281721/000095010315009486/0000950103-15-009486-index.htm
2008-10-31F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1281721/000101915508000736/0001019155-08-000736-index.htm
2019-02-15F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1281721/000101915519000042/0001019155-19-000042-index.htm
2008-10-10F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1281721/000110465908063385/0001104659-08-063385-index.htm
2019-03-06F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1281721/000114420419012577/0001144204-19-012577-index.htm
2009-02-20RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1281721/000115955409000006/0001159554-09-000006-index.htm
2014-01-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281721/000119312514026422/0001193125-14-026422-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281721/000119312520034700/0001193125-20-034700-index.htm
2015-08-04F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1281721/000119380515001295/0001193805-15-001295-index.htm
2016-04-25F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1281721/000119380516003117/0001193805-16-003117-index.htm
2018-06-26F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1281721/000119380518000914/0001193805-18-000914-index.htm
2019-02-20F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1281721/000119380519000228/0001193805-19-000228-index.htm
2019-02-21F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1281721/000119380519000232/0001193805-19-000232-index.htm
2019-11-22F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1281721/000119380519001601/0001193805-19-001601-index.htm